Benitec Biopharma Earning Date (BNTC)

USA |NASDAQ |USD

BNTC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 12, 2022 (est) Mar 31, 2022 - $-0.59 $-0.82
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 12, 2022 (est) Mar 31, 2022 - $25.00K $1.00K

Benitec Biopharma's next estimated earnings date (based on same quarter last year's date) is May 12, 2022 for the fiscal quarter ending Mar 31, 2022.

BNTC Earnings Date & History Chart

BNTC Earnings & Revenue Forecast

BNTC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 0 $0.00 $0.00 $0.00
Jun 2023 0 $0.00 $0.00 $0.00

BNTC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / - $0.00 $0.00 $0.00
Jun 2023 0 / - $0.00 $0.00 $0.00

BNTC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 0 $0.00 $0.00 $0.00
Jun 2023 0 $0.00 $0.00 $0.00

BNTC Earnings Date & Revenue History

BNTC Earnings History

|
Show More
Show More

BNTC Revenue History

|
Show More
Show More

Benitec Biopharma Next Earnings Date & Report

BNTC Feb 2022 (FQ) Earnings Date & Report Preview

BNTC's next estimated earnings date (based on same quarter last year's report date) is May 12, 2022 for the fiscal quarter ending Mar 31, 2022.

Benitec Biopharma Previous Earnings Dates & Reports

BNTC Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Benitec Biopharma's previous earnings date was Feb 14, 2022 for its fiscal quarter ended Dec 31, 2021.

BNTC's earnings per share (EPS) was $-0.59.

The EPS was higher than the previous fiscal quarter (Sep 2021) by -4.44%, and higher than the same period a year before (Dec 2020) by -22.72%.

Revenues were $25.00K, up by 1124.29% from the previous quarter , and up by 2400.00% from the same period last year.

The company reported a net income of $-4.82M.

Free cash flow for the quarter was $-3.34M , compared to $-4.28M last quarter and $-3.50M a year before.

BNTC ended the quarter with $911.00K in total debt, a decrease of -4.51% compared to the previous quarter, and an increase of 192.93% compared to the same quarter a year before.

BNTC Previous Earnings Date & Report Recap: Jun 2021 (FY)

Benitec Biopharma's previous annual earnings date was Sep 20, 2021 for its fiscal year ended Jun 30, 2021.

BNTC's earnings per share (EPS) was $-4.79, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Jun 2020) by -41.85%.

Revenues were $59.00K, worse than the forecast of $110.00K by -46.36%, and down by -39.18% from previous year's revenue.

The company reported a net income of $-13.88M.

Benitec Biopharma reported a free cash flow of $-13.05M for its fiscal year, compared to $-7.63M a year ago.

The company ended the fiscal year with $213.00K in total debt, a decrease of -47.41% compared to the previous year.